These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38324123)

  • 1. Evodiamine inhibits growth of vemurafenib drug-resistant melanoma via suppressing IRS4/PI3K/AKT signaling pathway.
    Guo X; Huang S; Zhang Y; Wang H; Li L; Ran J; Chen D; Li X; Li J
    J Nat Med; 2024 Mar; 78(2):342-354. PubMed ID: 38324123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-
    Lei Y; Chan M; Liu H; Lyu W; Chen L; Zhong Y; Gan H; Wang M; Qi M; Guo Y; Liu J; Zhang E
    Dis Markers; 2022; 2022():4399334. PubMed ID: 35899176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHMFL-BMX-078, a BMX inhibitor, overcomes the resistance of melanoma to vemurafenib via inhibiting AKT pathway.
    Jiang S; Jiang T; Huang H; Chen X; Li L; Wang Z; Fei J; Liu C; Liu Z; Cheng Y
    Chem Biol Interact; 2022 Jan; 351():109747. PubMed ID: 34813779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications.
    Liu W; Stachura P; Xu HC; Umesh Ganesh N; Cox F; Wang R; Lang KS; Gopalakrishnan J; Häussinger D; Homey B; Lang PA; Pandyra AA
    J Exp Clin Cancer Res; 2020 Feb; 39(1):38. PubMed ID: 32085796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and augmented by ubiquitin-proteasome inhibition.
    Wang C; Li S; Wang MW
    Toxicol In Vitro; 2010 Apr; 24(3):898-904. PubMed ID: 20005289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evodiamine induces extrinsic and intrinsic apoptosis of ovarian cancer cells via the mitogen-activated protein kinase/phosphatidylinositol-3-kinase/protein kinase B signaling pathways].
    Wei L; Jin X; Cao Z; Li W
    J Tradit Chin Med; 2016 Jun; 36(3):353-9. PubMed ID: 27468551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin suppresses cell proliferation and triggers apoptosis in vemurafenib-resistant melanoma cells by downregulating the EGFR signaling pathway.
    Chiu YJ; Yang JS; Tsai FJ; Chiu HY; Juan YN; Lo YH; Chiang JH
    Environ Toxicol; 2022 Apr; 37(4):868-879. PubMed ID: 34994998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxyfadichalcone C inhibits melanoma A375 cell proliferation and metastasis via suppressing PI3K/Akt and MAPK/ERK pathways.
    Peng X; Wang Z; Liu Y; Peng X; Liu Y; Zhu S; Zhang Z; Qiu Y; Jin M; Wang R; Zhang Q; Kong D
    Life Sci; 2018 Aug; 206():35-44. PubMed ID: 29782872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms.
    Paraiso KH; Haarberg HE; Wood E; Rebecca VW; Chen YA; Xiang Y; Ribas A; Lo RS; Weber JS; Sondak VK; John JK; Sarnaik AA; Koomen JM; Smalley KS
    Clin Cancer Res; 2012 May; 18(9):2502-14. PubMed ID: 22351686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HI-511 overcomes melanoma drug resistance
    Chang X; Zhang T; Wang Q; Rathore MG; Reddy K; Chen H; Shin SH; Ma WY; Bode AM; Dong Z
    Theranostics; 2020; 10(21):9721-9740. PubMed ID: 32863956
    [No Abstract]   [Full Text] [Related]  

  • 11. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway.
    Yao X; Jiang W; Yu D; Yan Z
    Food Funct; 2019 Feb; 10(2):703-712. PubMed ID: 30663726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
    Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells.
    Hong Z; Wang Z; Zhou B; Wang J; Tong H; Liao Y; Zheng P; Jamshed MB; Zhang Q; Chen H
    Int J Oncol; 2020 Mar; 56(3):783-793. PubMed ID: 31922213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance.
    Radić M; Vlašić I; Jazvinšćak Jembrek M; Horvat A; Tadijan A; Sabol M; Dužević M; Herak Bosnar M; Slade N
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of resistance to vemurafenib leads to interleukin-10 production through an aberrant activation of Akt in a melanoma cell line.
    Inozume T; Tsunoda T; Morisaki T; Harada K; Shirasawa S; Kawamura T
    J Dermatol; 2018 Dec; 45(12):1434-1439. PubMed ID: 30222203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenib.
    Krayem M; Journe F; Wiedig M; Morandini R; Najem A; Salès F; van Kempen LC; Sibille C; Awada A; Marine JC; Ghanem G
    Eur J Cancer; 2016 Mar; 55():98-110. PubMed ID: 26790143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K/Akt/mTOR Signaling Pathway.
    Long J; Pi X
    Biomed Res Int; 2020; 2020():5149417. PubMed ID: 32733943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRS4 promotes the progression of non-small cell lung cancer and confers resistance to EGFR-TKI through the activation of PI3K/Akt and Ras-MAPK pathways.
    Hao P; Huang Y; Peng J; Yu J; Guo X; Bao F; Dian Z; An S; Xu TR
    Exp Cell Res; 2021 Jun; 403(2):112615. PubMed ID: 33894221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taraxasterol attenuates melanoma progression via inactivation of reactive oxygen species-mediated PI3K/Akt signaling pathway.
    Liu W; Yu Q; Wang F; Li Y; Zhang G; Tao S
    Hum Exp Toxicol; 2022; 41():9603271211069034. PubMed ID: 35128947
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluvastatin exerts an antitumor effect in vemurafenib-resistant melanoma cells.
    Nishiya M; Yasuhira S; Shibazaki M; Oikawa H; Masuda T; Maesawa C
    Anticancer Drugs; 2019 Jun; 30(5):451-457. PubMed ID: 30920401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.